Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest

Purpose. Acute kidney injury (AKI) is a common complication after out-of-hospital cardiac arrest (OHCA), leading to increased mortality and challenging prognostication. Our aim was to examine if urine biomarkers could early predict postarrest AKI and patient outcome. Methods. A prospective observati...

Full description

Saved in:
Bibliographic Details
Main Authors: Sigrid Beitland, Espen Rostrup Nakstad, Jens Petter Berg, Anne-Marie Siebke Trøseid, Berit Sletbakk Brusletto, Cathrine Brunborg, Christofer Lundqvist, Kjetil Sunde
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/4384796
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850168350043275264
author Sigrid Beitland
Espen Rostrup Nakstad
Jens Petter Berg
Anne-Marie Siebke Trøseid
Berit Sletbakk Brusletto
Cathrine Brunborg
Christofer Lundqvist
Kjetil Sunde
author_facet Sigrid Beitland
Espen Rostrup Nakstad
Jens Petter Berg
Anne-Marie Siebke Trøseid
Berit Sletbakk Brusletto
Cathrine Brunborg
Christofer Lundqvist
Kjetil Sunde
author_sort Sigrid Beitland
collection DOAJ
description Purpose. Acute kidney injury (AKI) is a common complication after out-of-hospital cardiac arrest (OHCA), leading to increased mortality and challenging prognostication. Our aim was to examine if urine biomarkers could early predict postarrest AKI and patient outcome. Methods. A prospective observational study of resuscitated, comatose OHCA patients admitted to Oslo University Hospital in Norway. Urine samples were collected at admission and day three postarrest and analysed for β-2-microglobulin (β2M), osteopontin, and trefoil factor 3 (TFF3). Outcome variables were AKI within three days according to the Kidney Disease Improving Global Outcome criteria, in addition to six-month mortality and poor neurological outcome (PNO) (cerebral performance category 3–5). Results. Among 195 included patients (85% males, mean age 60 years), 88 (45%) developed AKI, 88 (45%) died, and 96 (49%) had PNO. In univariate analyses, increased urine β2M, osteopontin, and TFF3 levels sampled at admission and day three were independent risk factors for AKI, mortality, and PNO. Exceptions were that β2M measured at day three did not predict any of the outcomes, and TFF3 at admission did not predict AKI. In multivariate analyses, combining clinical parameters and biomarker levels, the area under the receiver operating characteristics curves (95% CI) were 0.729 (0.658–0.800), 0.797 (0.733–0.861), and 0.812 (CI 0.750–0.874) for AKI, mortality, and PNO, respectively. Conclusions. Urine levels of β2M, osteopontin, and TFF3 at admission and day three were associated with increased risk for AKI, mortality, and PNO in comatose OHCA patients. This trail is registered with NCT01239420.
format Article
id doaj-art-d92e04fb70904ecaae0be6c6536e6b20
institution OA Journals
issn 2090-1305
2090-1313
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Critical Care Research and Practice
spelling doaj-art-d92e04fb70904ecaae0be6c6536e6b202025-08-20T02:20:58ZengWileyCritical Care Research and Practice2090-13052090-13132019-01-01201910.1155/2019/43847964384796Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac ArrestSigrid Beitland0Espen Rostrup Nakstad1Jens Petter Berg2Anne-Marie Siebke Trøseid3Berit Sletbakk Brusletto4Cathrine Brunborg5Christofer Lundqvist6Kjetil Sunde7Institute of Clinical Medicine, University of Oslo, P.O.Box 1072 Blindern, 0316 Oslo, NorwayNorwegian National Unit for CBRNE Medicine, Oslo University Hospital, P.O.Box 4956 Nydalen, 0424 Oslo, NorwayInstitute of Clinical Medicine, University of Oslo, P.O.Box 1072 Blindern, 0316 Oslo, NorwayDepartment of Medical Biochemistry, Oslo University Hospital, P.O.Box 4950 Nydalen, 0424 Oslo, NorwayDepartment of Medical Biochemistry, Oslo University Hospital, P.O.Box 4950 Nydalen, 0424 Oslo, NorwayOslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, P.O.Box 1122 Blindern, 0317 Oslo, NorwayInstitute of Clinical Medicine, University of Oslo, P.O.Box 1072 Blindern, 0316 Oslo, NorwayInstitute of Clinical Medicine, University of Oslo, P.O.Box 1072 Blindern, 0316 Oslo, NorwayPurpose. Acute kidney injury (AKI) is a common complication after out-of-hospital cardiac arrest (OHCA), leading to increased mortality and challenging prognostication. Our aim was to examine if urine biomarkers could early predict postarrest AKI and patient outcome. Methods. A prospective observational study of resuscitated, comatose OHCA patients admitted to Oslo University Hospital in Norway. Urine samples were collected at admission and day three postarrest and analysed for β-2-microglobulin (β2M), osteopontin, and trefoil factor 3 (TFF3). Outcome variables were AKI within three days according to the Kidney Disease Improving Global Outcome criteria, in addition to six-month mortality and poor neurological outcome (PNO) (cerebral performance category 3–5). Results. Among 195 included patients (85% males, mean age 60 years), 88 (45%) developed AKI, 88 (45%) died, and 96 (49%) had PNO. In univariate analyses, increased urine β2M, osteopontin, and TFF3 levels sampled at admission and day three were independent risk factors for AKI, mortality, and PNO. Exceptions were that β2M measured at day three did not predict any of the outcomes, and TFF3 at admission did not predict AKI. In multivariate analyses, combining clinical parameters and biomarker levels, the area under the receiver operating characteristics curves (95% CI) were 0.729 (0.658–0.800), 0.797 (0.733–0.861), and 0.812 (CI 0.750–0.874) for AKI, mortality, and PNO, respectively. Conclusions. Urine levels of β2M, osteopontin, and TFF3 at admission and day three were associated with increased risk for AKI, mortality, and PNO in comatose OHCA patients. This trail is registered with NCT01239420.http://dx.doi.org/10.1155/2019/4384796
spellingShingle Sigrid Beitland
Espen Rostrup Nakstad
Jens Petter Berg
Anne-Marie Siebke Trøseid
Berit Sletbakk Brusletto
Cathrine Brunborg
Christofer Lundqvist
Kjetil Sunde
Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest
Critical Care Research and Practice
title Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest
title_full Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest
title_fullStr Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest
title_full_unstemmed Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest
title_short Urine β-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest
title_sort urine β 2 microglobulin osteopontin and trefoil factor 3 may early predict acute kidney injury and outcome after cardiac arrest
url http://dx.doi.org/10.1155/2019/4384796
work_keys_str_mv AT sigridbeitland urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT espenrostrupnakstad urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT jenspetterberg urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT annemariesiebketrøseid urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT beritsletbakkbrusletto urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT cathrinebrunborg urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT christoferlundqvist urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest
AT kjetilsunde urineb2microglobulinosteopontinandtrefoilfactor3mayearlypredictacutekidneyinjuryandoutcomeaftercardiacarrest